Clinical relevance of MEFV gene mutations in Japanese patients with unexplained fever

Journal of Rheumatology

Volumn 39, Issue 4, 2012, Pages 875-877

  Migita, Kiyoshi ^a   Ida, Hiroaki ^b   Moriuchi, Hiroyuki ^c   Agematsu, Kazunaga ^d  

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^d SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; COLCHICINE; GLUTAMIC ACID; GLUTAMINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PROLINE; SERINE; STEROID;

ADULT; CLINICAL FEATURE; CONTROLLED STUDY; EXON; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; JAPANESE; LETTER; MAJOR CLINICAL STUDY; MALE; MEFV GENE; MOLECULAR PATHOLOGY; MONARTHRITIS; MUTATIONAL ANALYSIS; MUTATOR GENE; PATIENT ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; RHEUMATIC DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ARTHRITIS; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FEVER OF UNKNOWN ORIGIN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; MALE; MIDDLE AGED; POINT MUTATION; YOUNG ADULT;

EID: 84859464434     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110700     Document Type: Letter

References (9)

1. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879-85. (Pubitemid 27452541)
2. Ben-Chetrit E, Peleg H, Aamar S, Heyman SN. The spectrum of MEFV clinical presentations - Is it familial Mediterranean fever only? Rheumatology 2009;48:1455-9.
3. Ryan JG, Masters SL, Booty MG, Habal N, Alexander JD, Barham BK, et al. Clinical features and functional significance of the P369S/R408Q variant in pyrin, the familial Mediterranean fever protein. Ann Rheum Dis 2010;69:1383-8.
4. Marek-Yagel D, Berkun Y, Padeh S, Abu A, Reznik-Wolf H, Livneh A, et al. Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum 2009;60:1862-6.
5. Booty MG, Chae JJ, Masters SL, Remmers EF, Barham B, Le JM, et al. Familial Mediterranean fever with a single MEFV mutation: Where is the second hit? Arthritis Rheum 2009;60:1851-61.
6. Chae JJ, Cho YH, Lee GS, Cheng J, Liu PP, Feigenbaum L, et al. Gain-of-function pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice. Immunity 2011;34:755-68.
7. Ozen S. Changing concepts in familial Mediterranean fever: Is it possible to have an autosomal-recessive disease with only one mutation? Arthritis Rheum 2009;60:1575-7.
8. Ozen S, Berdeli A, Türel B, Kutlay S, Yalcinkaya F, Arici M, et al. Arg753Gln TLR-2 polymorphism in familial mediterranean fever: Linking the environment to the phenotype in a monogenic inflammatory disease. J Rheumatol 2006;33:2498-500. (Pubitemid 46067831)
9. Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, et al. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 2007;56:1706-12. (Pubitemid 46764102)